Literature DB >> 412589

Distribution and metabolism of prednisone in mice, dogs, and monkeys.

S M El Dareer, R F Struck, V M White, L B Mellett, D L Hill.   

Abstract

A chromatographic procedure that allows measurement of [3H]prednisone and [3H]prednisolone in biologic fluids and tissues was developed and used to determine some of the biochemical properties of prednisone and its distribution and metabolism in mice, dogs, and monkeys. When prednisone was added to mouse serum in vitro at a concentration of 50 microgram/ml, approximately half of the drug became bound to serum proteins. Homogenates of mouse liver metabolized prednisone to prednisolone. Following ip or oral doses of prednisone to mice, serum levels of prednisone, prednisolone, and other metabolites were maximum at 15 minutes. 20-Dihydroprednisolone was identified as a metabolite in several biologic samples. For dogs and monkeys given in iv dose of prednisone, disappearance from the serum was biphasic with apparent half-lives of 15 and 82 minutes and 33 and 78 minutes respectively. The serum levels of prednisone and prednisolone in mice, dogs, and monkeys were not increased beyond expected levels by simultaneous administration of iv doses of vincristine. The prednisone content of the kidneys, liver, intestine, and bile of a monkey killed 30 minutes after an iv dose was higher than that in serum. Oral doses of prednisone were absorbed erratically by dogs and monkeys. Only small amounts of prednisone and prednisolone were excreted in the urine of dogs and monkeys given an iv or oral dose.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412589

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  7 in total

1.  Dose dependent pharmacokinetics of prednisone and prednisolone in man.

Authors:  J Q Rose; A M Yurchak; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

2.  The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits.

Authors:  W F Ebling; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1986-12

3.  The combination of melphalan with prednisolone. Anti-tumor effect and normal tissue toxicity in laboratory systems.

Authors:  P J Selby; J L Millar; T A Phelps; M Y Gordon; R Wilkinson; T J McElwain
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 4.  Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.

Authors:  Rita Diehl; Fabienne Ferrara; Claudia Müller; Antje Y Dreyer; Damian D McLeod; Stephan Fricke; Johannes Boltze
Journal:  Cell Mol Immunol       Date:  2016-10-10       Impact factor: 11.530

5.  Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis.

Authors:  Lionel Sebbag; Yuqi Yan; Joe S Smith; Rachel A Allbaugh; Larry W Wulf; Jonathan P Mochel
Journal:  J Ocul Pharmacol Ther       Date:  2019-05-09       Impact factor: 2.671

6.  Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.

Authors:  R Shepherd; K R Harrap
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

7.  Pharmacokinetics of Oral Prednisone at Various Doses in Dogs: Preliminary Findings Using a Naïve Pooled-Data Approach.

Authors:  Lionel Sebbag; Jonathan P Mochel
Journal:  Front Vet Sci       Date:  2020-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.